If we look at the existing life science hot spots mentioned in the Draghi report, including Medicon Valley, it is obvious that the likelihood of success will increase dramatically, if we embrace the Golden Triangle in the UK (London- Oxford-Cambridge). This was one of the key findings in the recently published 2025 State of Medicon Valley Analysis focusing on European cluster, their individual strengths and the potential for collaboration.
Nordic Life Science Magazine just published the column “Bridging life science clusters in the EU and UK is the next step needed” by Medicon Valley Alliance chairman Niels Abel Bonde highlighting why any aspiration to rival China and the US and make Europe the most attractive global life science region by 2030 must include both the EU and the UK.